Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6250

  • The following term was not found in PubMed: Sudria-Andreu.
1.

Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).

Brenkman HJF, Gertsen EC, Vegt E, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Luyer MDP, Nieuwenhuijzen GAP, van Lanschot JJB, Lagarde SM, de Steur WO, Hartgrink HH, Stoot JHMB, Hulsewe KWE, Spillenaar Bilgen EJ, van Det MJ, Kouwenhoven EA, van der Peet DL, Daams F, van Sandick JW, van Grieken NCT, Heisterkamp J, van Etten B, Haveman JW, Pierie JP, Jonker F, Thijssen AY, Belt EJT, van Duijvendijk P, Wassenaar E, van Laarhoven HWM, Wessels FJ, Haj Mohammad N, van Stel HF, Frederix GWJ, Siersema PD, Ruurda JP; PLASTIC Study Group.

BMC Cancer. 2018 Apr 20;18(1):450. doi: 10.1186/s12885-018-4367-9.

PMID:
29678145
2.

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.

Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA.

JAMA. 2018 Apr 17;319(15):1566-1579. doi: 10.1001/jama.2018.2525.

PMID:
29677301
3.

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.

Reis H, van der Vos KE, Niedworok C, Herold T, Módos O, Szendrői A, Hager T, Ingenwerth M, Vis DJ, Behrendt MA, de Jong J, van der Heijden MS, Peyronnet B, Mathieu R, Wiesweg M, Ablat J, Okon K, Tolkach Y, Keresztes D, Nagy N, Bremmer F, Gaisa NT, Chlosta P, Kriegsmann J, Kovalszky I, Timar J, Kristiansen G, Radzun HJ, Knüchel R, Schuler M, Black P, Rübben H, Hadaschik B, Schmid KW, van Rhijn BWG, Nyirády P, Szarvas T.

Int J Cancer. 2018 Apr 19. doi: 10.1002/ijc.31547. [Epub ahead of print]

PMID:
29672836
4.

Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.

Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, Heymans J, Frankema JS, de Jong KP, Richel DJ, Prevoo W, Vlayen J.

Cardiovasc Intervent Radiol. 2018 Apr 17. doi: 10.1007/s00270-018-1959-3. [Epub ahead of print]

PMID:
29666906
5.

Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.

Verver D, van Klaveren D, van Akkooi ACJ, Rutkowski P, Powell BWEM, Robert C, Testori A, van Leeuwen BL, van der Veldt AAM, Keilholz U, Eggermont AMM, Verhoef C, Grünhagen DJ.

Eur J Cancer. 2018 Apr 13;96:25-33. doi: 10.1016/j.ejca.2018.02.022. [Epub ahead of print]

PMID:
29660597
6.

Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.

Jochems A, Leeneman B, Franken MG, Schouwenburg MG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ, van den Eertwegh AJM, Groenewegen G, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Koornstra RH, Kruit WHJ, Louwman MWJ, Piersma D, van Rijn RS, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, Uyl-de Groot CA, van der Hoeven KJM.

Anticancer Drugs. 2018 Apr 13. doi: 10.1097/CAD.0000000000000629. [Epub ahead of print]

PMID:
29659371
7.

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

Hellmann MD, Ciuleanu TE, Pluzanski A, Lee JS, Otterson GA, Audigier-Valette C, Minenza E, Linardou H, Burgers S, Salman P, Borghaei H, Ramalingam SS, Brahmer J, Reck M, O'Byrne KJ, Geese WJ, Green G, Chang H, Szustakowski J, Bhagavatheeswaran P, Healey D, Fu Y, Nathan F, Paz-Ares L.

N Engl J Med. 2018 Apr 16. doi: 10.1056/NEJMoa1801946. [Epub ahead of print]

8.

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Lichinitser M, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Maio M, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan P, Ibrahim N, Marreaud S, van Akkooi ACJ, Suciu S, Robert C.

N Engl J Med. 2018 Apr 15. doi: 10.1056/NEJMoa1802357. [Epub ahead of print]

9.

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy.

Winters BR, Vakar-Lopez F, Brown L, Montgomery B, Seiler R, Black PC, Boormans JL, Dall Era M, Davincioni E, Douglas J, Gibb EA, van Rhijn BWG, van der Heijden MS, Hsieh AC, Wright JL, Lam HM.

Urol Oncol. 2018 Apr 12. pii: S1078-1439(18)30098-X. doi: 10.1016/j.urolonc.2018.03.016. [Epub ahead of print]

PMID:
29657089
10.

Corrigendum to "An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)" [Eur J Cancer 75 (April 2017) 5-13].

Makama M, Drukker CA, Rutgers EJT, Slaets L, Cardoso F, Rookus MA, Tryfonidis K, Van't Veer LJ, Schmidt MK.

Eur J Cancer. 2018 Apr 12. pii: S0959-8049(18)30747-0. doi: 10.1016/j.ejca.2018.03.017. [Epub ahead of print] No abstract available.

PMID:
29656866
11.

The New Standard: Personalised Information about the Risks and Benefits of Treatment Strategies for Localised Prostate Cancer.

van Stam MA, van der Poel H.

Eur Urol. 2018 Apr 13. pii: S0302-2838(18)30199-4. doi: 10.1016/j.eururo.2018.03.018. [Epub ahead of print] No abstract available.

PMID:
29656852
12.

Physical behavior and associations with health outcomes in operable NSCLC patients: A prospective study.

Timmerman JGJ, Dekker-van Weering MGHM, Wouters MWJMM, Stuiver MMM, de Kanter WW, Vollenbroek-Hutten MMRM.

Lung Cancer. 2018 May;119:91-98. doi: 10.1016/j.lungcan.2018.03.006. Epub 2018 Mar 9.

PMID:
29656759
13.

Corrigendum to "Post-traumatic stress symptoms are associated with physical multimorbidity: Findings from the Adult Psychiatric Morbidity Survey 2007" [Journal of Affective Disorders 232 (2018) 385-392].

Jacob L, Haro JM, Koyanagi A.

J Affect Disord. 2018 Apr 12;235:168. doi: 10.1016/j.jad.2018.04.056. [Epub ahead of print] No abstract available.

PMID:
29656262
14.

Intramasseteric Schwanoma mimicking an isolated cheek mass: Case report and review of literature.

El Khatib N, Nehme A, Nasser S, Moukarzel N, Abtar HK.

Int J Surg Case Rep. 2018 Apr 7;46:24-27. doi: 10.1016/j.ijscr.2018.03.042. [Epub ahead of print]

15.

Correction: Energy expenditure in caving.

Antoni G, Marini E, Curreli N, Tuveri V, Comandini O, Cabras S, Gabba S, Madeddu C, Crisafulli A, Rinaldi AC.

PLoS One. 2018 Apr 13;13(4):e0196028. doi: 10.1371/journal.pone.0196028. eCollection 2018.

16.

Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.

Claassen YHM, van Sandick JW, Hartgrink HH, Dikken JL, De Steur WO, van Grieken NCT, Boot H, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH.

Br J Surg. 2018 May;105(6):728-735. doi: 10.1002/bjs.10773.

PMID:
29652082
17.

Variation in general supportive and preventive intensive care management of traumatic brain injury: a survey in 66 neurotrauma centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study.

Huijben JA, Volovici V, Cnossen MC, Haitsma IK, Stocchetti N, Maas AIR, Menon DK, Ercole A, Citerio G, Nelson D, Polinder S, Steyerberg EW, Lingsma HF, van der Jagt M; CENTER-TBI investigators and participants.

Crit Care. 2018 Apr 13;22(1):90. doi: 10.1186/s13054-018-2000-6.

18.

The WHO 1973 classification system for grade is an Important prognosticator in T1 non-muscle-invasive bladder cancer.

Fransen van de Putte EE, Bosschieter J, van der Kwast TH, Bertz S, Denzinger S, Manach Q, Compérat EM, Boormans JL, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Rouprêt M, Otto W, Burger M, Hartmann A, van Rhijn BWG.

BJU Int. 2018 Apr 10. doi: 10.1111/bju.14238. [Epub ahead of print]

PMID:
29637669
19.

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.

Franken MG, Leeneman B, Jochems A, Schouwenburg MG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ, van den Eertwegh AJM, de Groot JWB, van der Hoeven KJM, Hospers GAP, Kapiteijn E, Koornstra R, Kruit WHJ, Louwman MWJ, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, van Zeijl M, Haanen JBAG, Uyl-de Groot CA.

Anticancer Drugs. 2018 Apr 9. doi: 10.1097/CAD.0000000000000628. [Epub ahead of print]

PMID:
29634490
20.

[18F]fluoro-benziodoxole: a no-carrier-added electrophilic fluorinating reagent. Rapid, simple radiosynthesis, purification and application for fluorine-18 labelling.

Cortés González MA, Nordeman P, Bermejo Gómez A, Meyer DN, Antoni G, Schou M, Szabó KJ.

Chem Commun (Camb). 2018 Apr 10. doi: 10.1039/c8cc00526e. [Epub ahead of print]

PMID:
29632936

Supplemental Content

Loading ...
Support Center